ImmuMap has announced it is now offering enzyme-linked spot forming assay ELISpot for the analysis of antigen-specific T-cell responses. In addition to our continuous efforts within advanced ...
The COVID-19 pandemic renewed interest in vaccinations, and scientific advancements abound. Developers are continually working to create vaccines that elicit targeted, strong, and long-lasting immune ...
Randomized phase II trial evaluating the combination of TG4001, an HPV16 therapeutic vaccine, and avelumab (ave) in patients (pts) with immunotherapy-naïve recurrent and/or metastatic (R/M) ...
Because of the higher conservation of RSV Fusion (F) protein than the glycoprotein (G) across RSV strains and serotypes, the majority of vaccine candidates targets to viral fusion protein (F) rather ...
Table 3: Global ELISpot and FluoroSpot Assay Market, by Product, $Million, 2022-2033 Table 4: Global ELISpot and FluoroSpot Assay Market, by Assay Type, $Million ...
Over the past 30 years, enzyme-linked immunosorbent assay (ELISA) has become a ubiquitous tool across various research fields. It has numerous applications, from screening for human immunodeficiency ...
LAVAL, Québec--(BUSINESS WIRE)--Altasciences is pleased to announce the completion of its laboratory facilities in Columbia, MO. The newly expanded, 8,000-square-foot space, which includes a test ...
LAVAL, Québec--(BUSINESS WIRE)--Altasciences is pleased to announce the completion of its laboratory facilities in Columbia, MO. “Our integrated CRO/CDMO services combine bioanalytical services with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results